Alphonso Nichols, MD
Psychiatry · San Diego, CANPI 1003890666
Payments from drug & device makers
What this record shows
The money is spread across several categories — consulting fees (51.6%), speaking fees and food and beverage — rather than concentrated in one kind of arrangement. Ironshore Pharmaceuticals Inc. accounts for 64.6% of it on its own, with 9 other manufacturers making up the rest. Reporting peaked in 2019 at $6,709 and has fallen 99.4% since, to $40 in 2023. Among psychiatry clinicians in CA with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 36 payments — averaging $215.45 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Ironshore Pharmaceuticals Inc.$5K
- Sunovion Pharmaceuticals Inc.$2K
- Teva Pharmaceuticals USA, Inc.$113
- Otsuka America Pharmaceutical, Inc.$73
- Takeda Pharmaceuticals U.S.A., Inc.$56
- Tris Pharma Inc$48
- plus $101 from 4 others
What the payments were for
- Consulting fees$4,00052%
- Speaking & faculty fees$2,21729%
- Travel & lodging$6849%
- Food & beverage$75710%
- Education$991%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Ironshore Pharmaceuticals Inc. | 11 | $5,013 |
| Sunovion Pharmaceuticals Inc. | 8 | $2,353 |
| Teva Pharmaceuticals USA, Inc. | 2 | $113 |
| Otsuka America Pharmaceutical, Inc. | 4 | $73 |
| Takeda Pharmaceuticals U.S.A., Inc. | 4 | $56 |
| Tris Pharma Inc | 2 | $48 |
| Neurocrine Biosciences, Inc. | 1 | $32 |
| Jazz Pharmaceuticals Inc. | 1 | $24 |
| Adlon Therapeutics L.p. | 2 | $24 |
| Neos Therapeutics, LP | 1 | $21 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Jornay PM 20mg capsules (Bottle of 100)$4,806
- LATUDA$2,217
How this compares
$7,756 in reported general payments places this provider in the 90th percentile of 4,954 psychiatry providers in California.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Invega SustennaPaliperidone Palmitate | 12 | $28,657 |
| BelsomraSuvorexant | 11 | $4,951 |
| Lurasidone Hcl | 15 | $2,828 |
| Aripiprazole | 54 | $2,558 |
| Divalproex Sodium ErDivalproex Sodium | 24 | $1,384 |
| Bupropion XlBupropion Hcl | 84 | $1,362 |
| Quetiapine Fumarate | 110 | $1,151 |
| Atomoxetine Hcl | 16 | $808 |
| Trazodone Hcl | 111 | $741 |
| Olanzapine | 14 | $654 |
| Sertraline Hcl | 144 | $648 |
| Mirtazapine | 60 | $598 |
| Dextroamphetamine-AmphetamineDextroamphetamine/Amphetamine | 22 | $588 |
| Duloxetine Hcl | 38 | $568 |
| Venlafaxine Hcl ErVenlafaxine Hcl | 49 | $532 |
Paid to pharmacies, not to this prescriber.
Other psychiatry in San Diego
- Jonathan MeyerSan Diego$2.3M
- Sanjai RaoSan Diego$445K
- Murray SteinSan Diego$121K
- Gustavo AlvaOrange$5.8M
- John KooSan Francisco$3M
- Jason KelloggIrvine$2.7M
- Charles Tuan-Tu NguyenIrvine$2.1M
- Manoj WaikarLos Gatos$1.9M
- Gerald MaguireSan Juan Capistraco$1.8M
- Salima BrillmanSunnyvale$1.4M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.